Dr. Merajver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1991 - 1993- University of MichiganResidency, Internal Medicine, 1988 - 1991
University of Michigan Medical SchoolClass of 1987
Certifications & Licensure
MI State Medical License 1989 - 2027- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 574 citationsGenetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021Mary B. Daly, Tuya Pal, Michael Berry, Saundra S. Buys, Patricia I. Dickson
Journal of the National Comprehensive Cancer Network. 2021-01-06 - 311 citationsSomatic mutations in the BRCA1 gene in sporadic ovarian tumours.Sofia D. Merajver, Trinh Pham, Rosemarie F. Caduff, Martha Chen, Ellen L. Poy
Nature Genetics. 1995-04-01 - 262 citationsBRCA2 germline mutations in male breast cancer cases and breast cancer families.Fergus J. Couch, Linda M. Farid, Michelle L. Deshano, Sean V. Tavtigian, Kathleen A. Calzone
Nature Genetics. 1996-05-01
Journal Articles
- Disparities in Genetic Services Utilization in a Random Sample of Young Breast Cancer SurvivorsSofia D Merajver, Kara J Milliron, Nature
Abstracts/Posters
- Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adult...Sofia Merajver, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Other
- Overview of the treatment of newly diagnosed, non-metastatic breast cancerMerajver SD, Taghian A, El-Ghamry MN
http://www.uptodate.com/contents/overview-of-the-treatment-of-newly-diagnosed-non-metastatic-breast-
UpToDate, Wolters Kluwer Health - 2013-04-03 - Inflammatory breast cancer: Pathology and molecular pathogenesisMerajver SD
http://www.uptodate.com/contents/inflammatory-breast-cancer-pathology-and-molecular-pathogenesis
UpToDate, Wolters Kluwer Health - 2012-04-12 - Inflammatory breast cancer: Clinical features and treatmentMerajver SD, Taghian A, El-Ghamry MN
http://www.uptodate.com/contents/inflammatory-breast-cancer-clinical-features-and-treatment
UpToDate, Wolters Kluwer Health - 2012-10-05
Press Mentions
Telephone Counseling Works for Breast Cancer-Gene TestsJanuary 23rd, 2014
Capturing Circulating Cancer Cells Could Provide Insights into How Disease SpreadsDecember 11th, 2012- Cell Movement Provides Clues to Aggressive Breast CancerOctober 4th, 2011
Grant Support
- Prevention Of Mammary Cancer In Her-2neu Transgenic MiceNational Cancer Institute1999–2007
- Study Of Tetrathiomolybdate (TM) As A Decoppering And Antiangiogenesis Of CancerNational Center For Research Resources1998–2002
- Families With Genetic Susceptibility To Breast CancerNational Center For Research Resources1997–2000
- Phase I Study Of Tetrathymolybdate In Metastatic CancerNational Cancer Institute1997–1998
- Analysis Of Families With Genetic Susceptibility To Breast CancerNational Center For Research Resources1996
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
